IQ Global Equity R&D Leaders ETF (WRND)
| Assets | $4.28M |
| NAV | $21.41 |
| Expense Ratio | 0.18% |
| PE Ratio | 16.97 |
| Shares Out | 200,000 |
| Dividend (ttm) | $0.06 |
| Dividend Yield | 0.26% |
| Ex-Dividend Date | Mar 18, 2022 |
| 1-Year Return | -14.28% |
| Volume | n/a |
| Open | 0.00 |
| Previous Close | 21.53 |
| Day's Range | 21.04 - 23.53 |
| 52-Week Low | 21.04 |
| 52-Week High | 25.44 |
| Beta | -1.13 |
| Holdings | 205 |
| Inception Date | Feb 8, 2022 |
About WRND
The underlying index seeks to provide exposure to innovative companies by investing in the equities of companies that have high research and development ("R&D") spending around the world. The fund invests, under normal circumstances, at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the investments included in its underlying index. The fund is non-diversified.
Top 10 Holdings
28.46% of assets| Name | Symbol | Weight |
|---|---|---|
| Amazon.com | AMZN | 4.81% |
| Alphabet | GOOGL | 3.70% |
| Meta Platforms | FB | 3.57% |
| Apple | AAPL | 2.87% |
| Microsoft | MSFT | 2.81% |
| Samsung Electronics Co Ltd | 005930.KS | 2.36% |
| Volkswagen AG Participating Preferred | VOW3.DE | 2.15% |
| Johnson & Johnson | JNJ | 2.13% |
| Merck & Co. | MRK | 2.05% |
| Pfizer | PFE | 2.02% |
News
IndexIQ Launches R&D-Focused ETF Trio
New York Life's ETF brand is targeting companies that spend big on research.
IndexIQ Launches Trio of Growth ETFs
IndexIQ has expanded its ETF product lineup with the launch of three new equity-focused strategies. The new trio of funds — the IQ U.S. Large Cap R&D Leaders ETF (LRND), the IQ U.S. Mid Cap R&D Leaders ...
IndexIQ Introduces ETF Suite Focused on Leaders in Research & Development
NEW YORK--(BUSINESS WIRE)--New IndexIQ ETFs are designed to provide exposure to companies positioned for future innovation and expansion through sustained investment in R&D.